Read + Share
Belada D, Kopeckova K, Bergua Burgues JM, Stevens D, et al. Safety and efficacy of tafasitamab with or without lenalidomide added to
first-line R-CHOP for DLBCL: the phase 1b First-MIND study. Blood 2023;142:1348-1358.
PMID: 37369099
|
 |
|
Belada D, Kopeckova K, Bergua Burgues JM, Stevens D, et al. Safety and efficacy of tafasitamab with or without lenalidomide added to
first-line R-CHOP for DLBCL: the phase 1b First-MIND study. Blood 2023;142:1348-1358.
PMID: 37369099
|
|
|
|